Concomitant Septal Myectomy with Aortic Valve Replacement for Severe Aortic Stenosis with Left Ventricular Outflow Tract Obstruction

Overview

Journal Juntendo Iji Zasshi

Specialty General Medicine

Date 2024 Jun 10

PMID 38855434

Authors

Akiko Umetsu

Satoshi Matsushita

Takeshi Kinoshita

Minoru Tabata

Affiliations

Soon will be listed here.

Abstract

Objectives: Septal myectomy confers survival benefits on patients with hypertrophic cardiomyopathy. However, its role in the treatment of severe aortic stenosis (sAS) with left ventricular outflow tract obstruction (LVOTO) remains under investigation. Another challenging question in the era of transcatheter aortic valve replacement is who would benefit more from traditional surgical aortic valve replacement (SAVR) with myectomy. Therefore, this study aimed to investigate myectomy cases at our hospital in Japan.

Methods: A total of 740 patients who underwent SAVR for sAS between 2012 and 2019 were identified. The demographics and baseline echocardiographic findings were retrospectively compared between patients who underwent concomitant myectomy and those who did not. The myectomy group was further assessed for factors predisposing to LVOTO, operative details, echocardiographic changes, and prognosis. The resected septa were histopathologically analyzed.

Results: The myectomy group mostly comprised elderly females with a small hypercontractile heart. Myectomy with SAVR led to statistically significant improvements in concentric left ventricular hypertrophy and LVOTO parameters. Survival was comparable with that reported in previous reports, even in the elderly subset (≥ 75 years). The septa showed mild fibrosis.

Conclusions: Myectomy can be safely performed with SAVR for sAS with LVOTO, even in the elderly, and it effectively improves LVOTO. Special attention should be paid to elderly females with relatively more severe AS and a small yet extra-hypertrophic and extra-hypercontractile heart. Such patients warrant comprehensive assessment of LVOTO, and despite its invasiveness, SAVR may be potentially more beneficial by allowing direct observation of LVOTO and ancillary myectomy.

References

Tommaso L, Stassano P, Mannacio V, Russolillo V, Monaco M, Pinna G . Asymmetric septal hypertrophy in patients with severe aortic stenosis: the usefulness of associated septal myectomy. J Thorac Cardiovasc Surg. 2012; 145(1):171-5. DOI: 10.1016/j.jtcvs.2011.10.096. View

Haley J, Sinak L, Tajik A, Ommen S, Oh J . Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: an important cause of new systolic murmur and cardiogenic shock. Mayo Clin Proc. 1999; 74(9):901-6. DOI: 10.4065/74.9.901. View

Mathew J, Dearani J, Daly R, Schaff H . Management of Subaortic Left Ventricular Outflow Tract Obstruction After Aortic Valve Replacement. Ann Thorac Surg. 2020; 112(5):1468-1473. DOI: 10.1016/j.athoracsur.2020.11.024. View

Ginter E, Simko V . Women live longer than men. Bratisl Lek Listy. 2013; 114(2):45-9. DOI: 10.4149/bll_2013_011. View

Choudhury L, Mahrholdt H, Wagner A, Choi K, Elliott M, Klocke F . Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40(12):2156-64. DOI: 10.1016/s0735-1097(02)02602-5. View

Azevedo C, Nigri M, Higuchi M, Pomerantzeff P, Spina G, Sampaio R . Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010; 56(4):278-87. DOI: 10.1016/j.jacc.2009.12.074. View

Suh W, Witzke C, Palacios I . Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010; 76(4):616-20. DOI: 10.1002/ccd.22609. View

Dawkins S, Hobson A, Kalra P, Tang A, Monro J, Dawkins K . Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg. 2007; 85(1):108-12. DOI: 10.1016/j.athoracsur.2007.08.024. View

Maron M, Appelbaum E, Harrigan C, Buros J, Gibson C, Hanna C . Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2009; 1(3):184-91. DOI: 10.1161/CIRCHEARTFAILURE.108.768119. View

10.

Koyama T, Okura H, Kume T, Fukuhara K, Imai K, Hayashida A . Impact of energy loss index on left ventricular mass regression after aortic valve replacement. J Echocardiogr. 2014; 12:51-8. PMC: 4042008. DOI: 10.1007/s12574-013-0196-7. View

11.

OHanlon R, Grasso A, Roughton M, Moon J, Clark S, Wage R . Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):867-74. DOI: 10.1016/j.jacc.2010.05.010. View

12.

Seiler C, Hess O, Schoenbeck M, Turina J, Jenni R, Turina M . Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol. 1991; 17(3):634-42. DOI: 10.1016/s0735-1097(10)80176-7. View

13.

Kayalar N, Schaff H, Daly R, Dearani J, Park S . Concomitant septal myectomy at the time of aortic valve replacement for severe aortic stenosis. Ann Thorac Surg. 2010; 89(2):459-64. DOI: 10.1016/j.athoracsur.2009.10.065. View

14.

Wigle E, Sasson Z, Henderson M, Ruddy T, FULOP J, Rakowski H . Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985; 28(1):1-83. DOI: 10.1016/0033-0620(85)90024-6. View

15.

Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V . Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009; 120(7):577-84. DOI: 10.1161/CIRCULATIONAHA.108.847772. View

16.

Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P . 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142(25):e558-e631. DOI: 10.1161/CIR.0000000000000937. View

17.

Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V . Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7):984-91. DOI: 10.1161/01.cir.0000051865.66123.b7. View

18.

Chockalingam A, Dorairajan S, Bhalla M, Dellsperger K . Unexplained hypotension: the spectrum of dynamic left ventricular outflow tract obstruction in critical care settings. Crit Care Med. 2008; 37(2):729-34. DOI: 10.1097/CCM.0b013e3181958710. View

19.

Foroutan F, Guyatt G, OBrien K, Bain E, Stein M, Bhagra S . Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ. 2016; 354:i5065. PMC: 5040922. DOI: 10.1136/bmj.i5065. View

20.

Lang R, Badano L, Mor-Avi V, Afilalo J, Armstrong A, Ernande L . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3):233-70. DOI: 10.1093/ehjci/jev014. View